Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 8 (August)

1. Electroconvulsive therapy in pregnancy.
   Obstet Gynecol, 110(2): 465-6. [Abstract] [Full-text]
2. Antidepressant-Induced Hypomania in Treatment-Resistant Depression.
   J Psychiatr Pract, 13(4): 233-237. [Abstract] [Full-text]
3. Facial emotion processing in acutely ill and euthymic patients with pediatric bipolar disorder.
   J Am Acad Child Adolesc Psychiatry, 46(8): 1070-9. [Abstract] [Full-text]
4. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
   Am J Psychiatry, 164(8): 1242-9. [Abstract] [Full-text]
5. Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation.
   Am J Psychiatry, 164(8): 1238-41. [Abstract] [Full-text]
6. The bipolar disorder phenome database: a resource for genetic studies.
   Am J Psychiatry, 164(8): 1229-37. [Abstract] [Full-text]
7. A longitudinal study of the use of mental health services by persons with serious mental illness: do Spanish-speaking Latinos differ from English-speaking Latinos and Caucasians?
   Am J Psychiatry, 164(8): 1173-80. [Abstract] [Full-text]
8. Maintenance treatment in bipolar disorder: a focus on aripiprazole.
   Expert Rev Neurother, 7(8): 919-25. [Abstract] [Full-text]
9. Comorbid substance use disorder in women with bipolar disorder associated with criminal arrest.
   Bipolar Disord, 9(5): 536-40. [Abstract] [Full-text]
10. Risk of suicide attempt and suicide death in patients treated for bipolar disorder.
    Bipolar Disord, 9(5): 526-30. [Abstract] [Full-text]
11. Brain-derived neurotrophic factor (BDNF) gene not associated with antidepressant-induced mania.
    Bipolar Disord, 9(5): 521-5. [Abstract] [Full-text]
12. Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA.
    Bipolar Disord, 9(5): 513-20. [Abstract] [Full-text]
13. White matter abnormalities observed in bipolar disorder: a diffusion tensor imaging study.
    Bipolar Disord, 9(5): 504-12. [Abstract] [Full-text]
14. Aggression, hostility, and irritability in children at risk for bipolar disorder.
    Bipolar Disord, 9(5): 496-503. [Abstract] [Full-text]
15. Stability of self-esteem in bipolar disorder: comparisons among remitted bipolar patients, remitted unipolar patients and healthy controls.
    Bipolar Disord, 9(5): 490-5. [Abstract] [Full-text]
16. Impaired working memory monitoring in euthymic bipolar patients.
    Bipolar Disord, 9(5): 478-89. [Abstract] [Full-text]
17. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients.
    Bipolar Disord, 9(5): 468-77. [Abstract] [Full-text]
18. Mood and anxiety spectrum as a means to identify clinically relevant subtypes of bipolar I disorder.
    Bipolar Disord, 9(5): 462-7. [Abstract] [Full-text]
19. Personality and the predisposition(s) to bipolar disorder: heuristic benefits of a two-dimensional model.
    Bipolar Disord, 9(5): 453-61. [Abstract] [Full-text]
20. Nutrition and exercise behavior among patients with bipolar disorder.
    Bipolar Disord, 9(5): 443-52. [Abstract] [Full-text]
21. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Bipolar Disord, 9(5): 435-42. [Abstract] [Full-text]
22. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
    BMC Psychiatry, 7: 33. [Abstract] [Full-text]
23. Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders.
    Expert Opin Pharmacother, 8(11): 1693-710. [Abstract] [Full-text]
24. Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?
    Expert Opin Pharmacother, 8(11): 1615-28. [Abstract] [Full-text]
25. Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology.
    J Neurosci Methods, 165(2): 198-209. [Abstract] [Full-text]
26. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.
    Neuropsychopharmacology, 32(9): 1888-902. [Abstract] [Full-text]
27. Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder.
    Curr Med Res Opin, 23(8): 1997-2004. [Abstract] [Full-text]
28. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
    Cell Mol Life Sci, 64(16): 2090-103. [Abstract] [Full-text]
29. Pharmacotherapeutic strategies for pediatric bipolar disorder.
    Expert Opin Pharmacother, 8(12): 1801-19. [Abstract] [Full-text]
30. Marital distress and DSM-IV psychiatric disorders in a population-based national survey.
    J Abnorm Psychol, 116(3): 638-43. [Abstract] [Full-text]
31. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
    BMC Psychiatry, 7(1): 40. [Abstract] [Full-text]
32. Region-of-interest-based analysis with application of cortical thickness variation of left planum temporale in schizophrenia and psychotic bipolar disorder.
    Hum Brain Mapp. [Abstract] [Full-text]
33. Relation of temperament and character properties with clinical presentation of bipolar disorder.
    Compr Psychiatry, 48(5): 446-51. [Abstract] [Full-text]
34. Chronic valproic acid intoxication: reversal by naloxone.
    Emerg Med J, 24(9): 677-8. [Abstract] [Full-text]
35. Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population.
    Soc Psychiatry Psychiatr Epidemiol, 42(9): 690-7. [Abstract] [Full-text]
36. Specificity of facial expression labeling deficits in childhood psychopathology.
    J Child Psychol Psychiatry, 48(9): 863-71. [Abstract] [Full-text]
37. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness.
    J Child Psychol Psychiatry, 48(9): 852-62. [Abstract] [Full-text]
38. Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants.
    Biol Psychiatry, 62(5): 391-9. [Abstract] [Full-text]
39. Electroconvulsive seizures stimulate glial proliferation and reduce expression of Sprouty2 within the prefrontal cortex of rats.
    Biol Psychiatry, 62(5): 505-12. [Abstract] [Full-text]
40. Environmental risk factors for attention-deficit hyperactivity disorder.
    Acta Paediatr, 96(9): 1269-74. [Abstract] [Full-text]
41. Self-reported care needs of outpatients with a bipolar disorder in the Netherlands.
    J Psychiatr Ment Health Nurs, 14(6): 549-57. [Abstract] [Full-text]
42. Identification of rare mutations of synaptogyrin 1 gene in patients with schizophrenia.
    J Psychiatr Res, 41(12): 1027-31. [Abstract] [Full-text]
43. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications.
    J Psychiatr Res, 41(12): 979-90. [Abstract] [Full-text]
44. Cognitive functioning in elderly patients with early onset bipolar disorder.
    Int J Geriatr Psychiatry, 22(9): 856-61. [Abstract] [Full-text]
45. Residential Mobility Among Patients in the VA Health System: Associations with Psychiatric Morbidity, Geographic Accessibility, and Continuity of Care.
    Adm Policy Ment Health, 34(5): 448-55. [Abstract] [Full-text]
46. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in bipolar disorder.
    Psychiatr Genet, 17(5): 304-7. [Abstract] [Full-text]
47. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
    Am J Psychiatry, 164(9): 1348-55. [Abstract] [Full-text]
48. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
    Am J Psychiatry, 164(9): 1340-7. [Abstract] [Full-text]
49. Sequence variation in DOCK9 and heterogeneity in bipolar disorder.
    Psychiatr Genet, 17(5): 274-86. [Abstract] [Full-text]
50. Serotonergic candidate genes and puerperal psychosis: an association study.
    Psychiatr Genet, 17(5): 253-60. [Abstract] [Full-text]
51. Residual symptoms in bipolar disorder: the effect of the last episode after remission.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(7): 1387-92. [Abstract] [Full-text]
52. The role of hippocampus in the pathophysiology of bipolar disorder.
    Behav Pharmacol, 18(5): 419-30. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.